The commissioners agreed to a settlement of $51,000, $49,500 of which will go to Frenchko’s lawyers, which included Dave ...

Talking shop while breaking bread should be fun. We’ve travelled the country to find the best restaurants for business.

What happens when you put anti-stress balls in a vacuum chamber? 🤔 BBC Boss Tim Davie outlined a national plan to switch off ...

Though all bourbon is whiskey, not all whiskey is bourbon. So, what sets them apart? Here are the key things to know about ...

Under the agreement, GSK will acquire BP Asset IX, a subsidiary of Boston Pharmaceuticals, for up to $2 billion in total cash ...

The new acquisition from Boston Pharmaceuticals adds to a wave of dealmaking undertaken by GSK to build its liver disease ...

Akero Therapeutics, Inc.’s AKRO share price has dipped by 6.47%, which has investors questioning if this is right time to buy ...

GSK plans to purchase an experimental drug for the liver disease MASH from Boston Pharmaceuticals for $1.2 billion upfront.

With its sweeping beach, pretty Victorian cottages and rich royal heritage, there’s an unassuming elegance to unfashionable ...

GSK is acquiring an experimental medicine from a Cambridge biotech to shore up its drug pipeline and muscle into the ...

With traditional pie and mash shops in jeopardy, a slice of London’s history is under threat of fading away The Standard's journalism is supported by our readers. When you purchase through links on ...

GSK has agreed to pay $1.2 billion upfront to acquire rights to efimosfermin from Cambridge, Massachusetts-based Boston ...